Virtue Diagnostics Honored with the
2023 Best Enterprise Award in IVD and Life Sciences

On August 18, 2023, Haoyue Capital, an industry-focused investment bank specializing in China’s healthcare sector, officially released the “2023 7th Annual Healthcare Investment Excellence Awards” . Virtue Diagnostics proudly clinched the “2023 Best Enterprise Award in IVD and Life Sciences.”

As a highly esteemed fixture in the industry since their inception in 2017, the Healthcare Investment Excellence Awards have consistently upheld the principles of fairness, impartiality, and objectivity. Employing a one-institution, one-vote format, the awards meticulously evaluate key metrics including investment activity, transaction quantity, transaction amount, and investment returns. These assessments rely on publicly disclosed information and submissions from various organizations, culminating in the annual recognition of outstanding investment institutions. Moreover, the Excellence Awards extend their accolades to exceptional healthcare enterprises spanning innovative pharmaceuticals, medical devices, IVD, life sciences, medical services, and smart healthcare. Their overarching goal is to establish a credible and influential investment ranking that sets new benchmarks for industry progress and fosters fresh avenues for investment and collaboration.